October 1, 2010by Barry P. Latner, M.D., Medical Director of Laboratory Services
Although Shakespeare did not have this question in mind when he wrote Hamlet, it is an appropriate one to consider when completing a laboratory test requisition. C-reactive protein (CRP) is one of the most sensitive acute phase proteins and appears to be a nonspecific host defense against inflammation... more...
Effective August 4, 2010 the name of the test "UA conditional" (15015) will be changing. The test will now be named UA with Microscopic (C&S if indicated). When this test is ordered, a complete urinalysis is performed which includes... more...
Outbreak Norovirus specimens are processed at California State Public Health laboratories. They are currently charging for this service. In the event of a facility or regional outbreak, State laboratories are prepared to process specimens rapidly and are able to track the progress of outbreaks throughout the State. If a Norovirus Outbreak is suspected,... more...
April 1, 2010by Barry P. Latner, M.D., Medical Director
Tuberculosis remains a contemporary disease. Since 1993, the proportion of cases in the United States has increased each year in foreign-born vs. U.S. born individuals. By 2007, the TB rate among immigrants was 9.7 times higher than in U.S.-born citizens... more...
June 30, 2009by Barry Latner, M.D., Medical Director Laboratory Services, John Muir Health
At the time of this writing, the World Health Organization (WHO) has changed the phase of pandemic alert for the novel Influenza A (H1N1) virus from Phase 5 to Phase 6. This indicates a global pandemic is underway in which there is little or no immunity in the population. While the upgrade designation is... more...
Allergy and diseases caused or complicated by allergy, such as asthma, or diseases with symptoms which mimic allergy, are among the most widespread and costly health problems in the world. John Muir Health, MuirLab will soon provide testing for allergy that is safe, simple, and accurate with groundbreaking technology with the latest generation... more...
Beginning May 1, 2009 MuirLab changed its method of high risk HPV to a newly FDA-approved molecular methodology from Hologic, Inc. While we have been very satisfied with the performance of our previous assay, market forces have eliminated that manufacturer from the HPV cytology product line more...
In our continuing commitment to provide innovative laboratory services for patients and physicians, John Muir Health and MuirLab are pleased to offer the next evolution in HIV-1 viral load testing, the COBAS® AmliPrep/Taqman HIV-1 test by Roche Diagnostics. This FDA-approved real time... more...
October 1, 2008by Barry P. Latner, M.D. Medical Director, Laboratory Services
The manufacturer of our Estradiol assay has updated its standardization to the international reference method of isotope dilution gas chromatography mass spectrometry (ID-GCMS) method from the USP reference material. As a result, there are some changes... more...
On March 31, 2008, the Microbiology Department will be moving to the new MuirLab Core Lab in Concord. In order to expedite STAT gram stains on specimens that will need to be read in the hospital, we are requesting that two swabs of the specimen be submitted to the Laboratory. One swab will be used to make the gram stain and the second... more...
May 1, 2008by Barry P. Latner, M.D., Medical Director, Laboratory Services
In 2004 the clinical laboratories of John Muir Health started reporting estimated glomerular filtration rate (eGFR) along with serum/plasma creatinine as recommended by the National Kidney Foundation. The rationale for this was to remind us that approximately 11% of the U.S. adult population has chronic kidney disease,... more...
May 1, 2008by Nader Shihabi, MD and Bernard Larner, MD
We are changing the criteria for reflex urine cultures. In the past, the only criteria for urine cultures was WBC >10 in the urine. We will now also culture urines with positive leukocyte esterase or positive nitrite. These two parameters were... more...
Effective April 1, 2008, "CBC with Auto Differential" and "CBC with Manual Differential" will be combined into a single test, "CBC with Differential". Automated or manual differential results will be reported based upon internal laboratory reflex criteria. If specific morphologic evaluation... more...
January 1, 2008by Barry P. Latner, M.D., Medical Director, Laboratory Services, John Muir Health
In September (2007) the Clinical Laboratories of John Muir Health introduced a new assay for cTnI and implemented reporting practice guidelines published in the laboratory literature and endorsed by all major cardiology organizations (including ACC and AHA). A significant guideline for cTnI was the decision-limit for myocardial injury/myocardial-cell necrosis being set at the 99th percentile of a population of normal, healthy individuals... more...
Despite recent improved access to antiretroviral treatment and care in many regions of the world, the AIDS pandemic claimed between 2.4 and 3.3 million lives in 2005, the highest number since 1981. Half a million or more than 570,000 of these deaths were children less than 15 years old... more...
The genus Legionella includes over 40 different species of fastidious Gram-negative bacilli. While these organisms represent normal environmental flora, many have been shown to cause human disease, most commonly opportunistic pneumonia in immunocompromised patients. The vast majority of such cases... more...
In an attempt to remind clinicians of the importance of the degree of protein binding in the action of phenytoin and in the interpretation of serum/plasma phenytoin concentrations, the Clinical Laboratories of John Muir Health will soon report... more...
The PLAC test is a blood test that measures the level of Lp-PLA2, an enzyme highly specific for vascular inflammation and implicated in the formation of rupture-prone plaque. The PLAC test is cleared by the FDA to aid in assessing risk of both coronary heart disease and ischemic stroke associated... more...
Enterohemorrhagic E. coli (EHEC), also known as Shiga-toxin-producing E. coli (STEC), is recognized as an important cause of human diarrhea, hemorrhagic colitis, thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). The E. coli serotype O157:H7 has been documented as the most common... more...
Beginning September 11, 2007 the Clinical Laboratories of John Muir Health will complete the conversion of all of its chemistry and immunochemistry assays (> 70 tests) to a single new platform. This change to Beckman Coulter instrumentation is made... more...